Institut Claudius Regaud

corporate_fareorganization

Institut Claudius Regaud

- Funding / Projects
  (74)

74 Projects, page 1 of 15

Prospective study of the relevance of T- lymphocytes tumor infiltrates CD8 and Foxp3 as a new prognostic biomarker in breast cancer treated by neoadjuvant chemotherapy.
assignment_turned_inProjectPartners:Institut Gustave Roussy, Hôpital Jean Minjoz, Centre Léon Bérard, Institut de Cancérologie de Lorraine, Centre Jean Perrin +10 partners
Institut Gustave Roussy,
Hôpital Jean Minjoz,
Centre Léon Bérard,
Institut de Cancérologie de Lorraine,
Centre Jean Perrin,
Centre Paul Strauss,
Institut de Cancérologie de l'Ouest - ICO,
Institut Curie,
Institut Jean Godinot,
Centre Georges-François Leclerc,
Centre Léon Bérard,
Centre Eugène Marquis,
Institut Bergonié,
Institut Claudius Regaud,
Hôpital René Huguenin - Institut Curie
Funder: Institut National du Cancer Project Code: INCa-DGOS-3796
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
"Developing and coordinating multiple types of expertise (from researchers, technicians, users and """"non-human"""" elements) to reduce social inequalities in health (« Inégalités Sociales de Santé ») in interventional research at all stages and ages and for all genders and social environments of cancer"
assignment_turned_inProjectUntil 2022Partners:University of Toulouse, Université de Montréal, Médecins du Monde, Université Paul Sabatier Toulouse 3, CHU +1 partners
University of Toulouse,
Université de Montréal,
Médecins du Monde,
Université Paul Sabatier Toulouse 3,
CHU,
Institut Claudius Regaud
Funder: Institut National du Cancer Project Code: INCa-12532
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Cancer bronchique non à petites cellules : analyse différentielle de l'expression de biomarqueurs entre la tumeur primitive et les métastases
assignment_turned_inProject2009 - 2012Partners:Centre International de Recherche sur le Cancer, Institut Gustave Roussy, CHUG, Hôpital Côte de Nacre, INSERM UMR946 +1 partners
Centre International de Recherche sur le Cancer,
Institut Gustave Roussy,
CHUG,
Hôpital Côte de Nacre,
INSERM UMR946,
Institut Claudius Regaud
Funder: Institut National du Cancer Project Code: INCa-1308
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Evaluation of the predictive and prognostic value of germ line polymorphisms in patients with metastatic breast cancer.
assignment_turned_inProjectPartners:Hôpital Jean Minjoz, Institut Bergonié, Centre Léon Bérard, Centre Léon Bérard, Hôpital Dupuytren +9 partners
Hôpital Jean Minjoz,
Institut Bergonié,
Centre Léon Bérard,
Centre Léon Bérard,
Hôpital Dupuytren,
Institut Curie,
Institut Gustave Roussy,
Centre Antoine Lacassagne,
Centre François Baclesse,
Institut de Cancérologie de l'Ouest - ICO,
ICM-VAL D'AURELLE,
Institut Paoli-Calmettes- (IPC),
Centre Georges-François Leclerc,
Institut Claudius Regaud
Funder: Institut National du Cancer Project Code: INCa-DGOS-3715
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A non inferiority randomized multicenter phase III trial of axillary node dissection versus no axillary node dissection in case of positive sentinel lymph node in invasive breast cancer
assignment_turned_inProjectPartners:Hôpital de la Conception, Institut Paoli-Calmettes- (IPC), Hôpital de la Conception, Clinique Clémentville, Centre René Gauducheau +1 partners
Hôpital de la Conception,
Institut Paoli-Calmettes- (IPC),
Hôpital de la Conception,
Clinique Clémentville,
Centre René Gauducheau,
Institut Claudius Regaud
Funder: Institut National du Cancer Project Code: INCa-DGOS-5437
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Institut Claudius Regaud

Institut Claudius Regaud

74 Projects, page 1 of 15

Prospective study of the relevance of T- lymphocytes tumor infiltrates CD8 and Foxp3 as a new prognostic biomarker in breast cancer treated by neoadjuvant chemotherapy.

Cancer bronchique non à petites cellules : analyse différentielle de l'expression de biomarqueurs entre la tumeur primitive et les métastases

Evaluation of the predictive and prognostic value of germ line polymorphisms in patients with metastatic breast cancer.

A non inferiority randomized multicenter phase III trial of axillary node dissection versus no axillary node dissection in case of positive sentinel lymph node in invasive breast cancer

Loading